GBA1 and Parkinson disease: Furthermore, ALP inhibition and perturbed α-synuclein homeostasis observed in dopaminergic neurons derived from iPSC from PD patients with GBA mutations16, 42 require several days of small molecule chaperone treatment to be reversed (Yang et al., manuscript submitted).